soul trial oral semaglutide cardiovascular outcomes 2024 results nejm 🔴Cardiovascular with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants Oral Semaglutide and Cardiovascular Outcomes

Its a powerful, evidence-based tool that can help people achieve lasting weight loss and improve or even reverse chronic conditions like diabetes, high blood pressure, acid reflux and sleep apnea, says bariatric surgeon Scott Schimpke, MD

doi: 10.1038/s41598-019-49364-x 95 MartinsFLBaileyMAGirardiACC

That long-term option is especially important for people whove struggled with yo-yo dieting or with regaining lost weight

Research Dosing Protocols Clinical trial dosing provides the foundation for understanding Retatrutide response patterns

K., Bunkin, D

This hormone increases insulin release and slows digestion, helping to regulate blood sugar levels and manage body weight